The Patent Finder

Mission Therapeutics Limited

34 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Sep 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 9, 2027
    The maintenance fee for 1-Cyano-PYRROLIDINE Compounds as USP30 Inhibitors (US 10,343,992) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
  • 1 fee due Feb 27, 2027
    The maintenance fee for Compounds (US 10,392,380) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 1 fee due Jul 7, 2027
    The maintenance fee for Methodologies for measuring isopeptidase activity in biological samples in a high throughput manner (US 10,527,610) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for Cyanopyrrolidine derivatives as inhibitors for DUBs (US 10,590,075) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
  • 2 fees due Oct 2 to 16, 2027 · next Oct 2
  • 2 fees due Nov 5 to 19, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,926,307Compounds
In force
 · USPTO record
In forceUSPTO record
US 10,392,380Compounds
In force
 · USPTO record
In forceUSPTO record
US 10,774,078Compounds
In force
 · USPTO record
In forceUSPTO record
US 11,472,798Compounds
In force
 · USPTO record
In forceUSPTO record
US 11,993,595Compounds
In force
 · USPTO record
In forceUSPTO record
US 10,343,9921-Cyano-PYRROLIDINE Compounds as USP30 Inhibitors
In force
 · High confidence
In forceHigh confidence
US 10,689,3451-Cyano-PYRROLIDINE Compounds as USP30 Inhibitors
In force
 · High confidence
In forceHigh confidence
US 11,053,1981-Cyano-PYRROLIDINE Compounds as USP30 Inhibitors
In force
 · High confidence
In forceHigh confidence
US 11,066,3651-Cyano-PYRROLIDINE Compounds as USP30 Inhibitors
In force
 · High confidence
In forceHigh confidence
US 12,637,4261-Cyano-PYRROLIDINE Compounds as USP30 Inhibitors
In force
 · High confidence
In forceHigh confidence
10 of 34 patents shown.
Pro members see all 34.
Pro members: see all 34 patents
Also on record, not counted in the 34: 4 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited